Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage
- PMID: 8457383
- DOI: 10.1089/aid.1993.9.159
Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage
Abstract
It has been suggested that the V3 domain of human immunodeficiency virus type 1 (HIV-1) isolates has to interact with a cell-surface-associated or endosomal proteinase during virus entry into susceptible cells. To investigate this hypothesis, we examined the effect of several mutations in the V3 loop on its susceptibility to proteolytic cleavage by thrombin and cathepsin E and compared it with the effect of these mutations on viral infectivity. The data obtained indicate that, if an interaction between the V3 loop and a proteinase is indeed crucial for viral entry, the substrate requirements for such a proteinase(s) would have to be very complex. In particular, it seems unlikely that a single enzyme with a unique specificity would be able to interact with all of the different HIV-1 and HIV-2/SIV strains isolated so far. Therefore, one would have to postulate the involvement of several cellular proteinases, or proteases with multiple specificities, in V3-based viral tropism.
Similar articles
-
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?AIDS Res Hum Retroviruses. 1991 Jan;7(1):3-16. doi: 10.1089/aid.1991.7.3. AIDS Res Hum Retroviruses. 1991. PMID: 2015114
-
Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.Adv Enzyme Regul. 1996;36:325-47. doi: 10.1016/0065-2571(95)00016-x. Adv Enzyme Regul. 1996. PMID: 8869754
-
Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.Virology. 1999 May 10;257(2):491-501. doi: 10.1006/viro.1999.9670. Virology. 1999. PMID: 10329559
-
Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1.FEBS Lett. 1995 Jul 3;367(3):251-6. doi: 10.1016/0014-5793(95)00571-p. FEBS Lett. 1995. PMID: 7607317
-
Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.J Virol. 2001 Jun;75(12):5457-64. doi: 10.1128/JVI.75.12.5457-5464.2001. J Virol. 2001. PMID: 11356952 Free PMC article.
Cited by
-
The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells.J Virol. 1997 Feb;71(2):1036-45. doi: 10.1128/JVI.71.2.1036-1045.1997. J Virol. 1997. PMID: 8995623 Free PMC article.
-
A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.J Virol. 1996 Jul;70(7):4451-6. doi: 10.1128/JVI.70.7.4451-4456.1996. J Virol. 1996. PMID: 8676469 Free PMC article.
-
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.J Virol. 2006 Apr;80(8):4017-25. doi: 10.1128/JVI.80.8.4017-4025.2006. J Virol. 2006. PMID: 16571818 Free PMC article.
-
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.J Virol. 2002 Mar;76(6):2606-16. doi: 10.1128/jvi.76.6.2606-2616.2002. J Virol. 2002. PMID: 11861826 Free PMC article.
-
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.Virology. 2006 Sep 30;353(2):268-82. doi: 10.1016/j.virol.2006.04.043. Virology. 2006. PMID: 17039602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
